´ëÇѽÅÀåÇÐȸ (¿Â¶óÀÎ) KSN-IAC(Integrated Academic Conference) 2021 ÅëÇÕÇмú´ëȸ : 2021-05-08±³À°ÀÏÀÚ : 2021-05-08
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) KSN-IAC(Integrated Academic Conference) 2021 ÅëÇÕÇмú´ëȸ ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
´ã´çÀÚ : ´ëÇѽÅÀåÇÐȸ
¿¬¶ôó : 02-3486-8736
À̸ÞÀÏ :
ksn@ksn.or.kr ±³À°Á¾·ù : ³»°úÀÇ»çÇÐ
Âü¼®¿¹»óÀοø : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 80,000¿ø
ºñ°í 8¸¸¿ø (1ÀÏ µî·Ï½Ã 4¸¸¿ø) : Àü¹®ÀÇ(±³¼ö, ºÀÁ÷ÀÇ, °³¿øÀÇ)/4¸¸¿ø (1ÀÏ µî·Ï½Ã 2¸¸¿ø) : ÀüÀÓÀÇ, Àü°øÀÇ, °£È£»ç, ¾à»ç, ¿µ¾ç»ç, »çȸº¹Áö»ç, ÀÇ·á °ü·Ã Á¾»çÀÚ /¹«·á : ¸¸65¼¼ ÀÌ»ó ȸ¿ø(1956.12.31 ÀÌÀü Ãâ»ý),Çлý(´ëÇпø»ý Á¦¿Ü): ÇлýÁõ »çº» Á¦Ãâ ¡æ ¿Â¶óÀÎ µî·Ï ÈÄ ¸ÞÀÏ·Î Á¦Ãâ
ksn@ksn.or.kr ±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-08 ROOM3 08:50~09:15 Molecular pathogenesis in Fabry disease Á¤¼ºÃ¶(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 05-08 ROOM3 09:15~09:40 Modeling of Fabry disease using Patient derived iPSCs and application of gene therapy Á¤º´ÇÏ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 05-08 ROOM3 09:40~10:05 Pathogenesis and biomarker in Fabry nephropathy ÃÖ¼öÁ¤(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 05-08 ROOM3 10:05~10:30 Switch to treatment & neutralizing anti-drug antibody in Fabry disease ±è¼öÇö(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 05-08 ROOM3 10:50~11:15 When to start dialysis in elderly patients with CKD Çö¿µÀ²(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 05-08 ROOM3 11:15~11:40 Individualized approach to vascular access in accordance with their individual ESKD Life-Plan in elderly patients ¹Ú¿ì¿µ(°è¸íÀÇ´ë)
±³À°½Ã°£ 05-08 ROOM3 11:40~12:05 Development of a predictive mortality risk score a Korean eldery dialysis cohort ±Ç¼øÈ¿(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 05-08 ROOM3 12:05~12:30 Anemia Management Considering the Pathophysiology of Elderly Chronic Kidney Disease Patients ¾çÀç¿ø(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 05-08 ROOM3 13:40~14:05 Erythropoietin resistance in patients on maintenance dialysis Á¶ÀåÈñ(°æºÏÀÇ´ë)
±³À°½Ã°£ 05-08 ROOM3 14:05~14:30 Iron therapy in chronic kidney disease ¼º¼ö¾Æ(À»ÁöÀÇ´ë)
±³À°½Ã°£ 05-08 ROOM3 14:30~14:55 Hepcidin in chronic kidney diseas À¯°æµ·(¿ï»êÀÇ´ë)
±³À°½Ã°£ 05-08 ROOM3 14:55~15:20 Artificial intelligence for optimal anemia management in end-stage renal disease À¯ÅÂÇö(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 05-08 ROOM3 15:40~16:10 New evidence for acute management of hyponatremia ¹é¼±ÇÏ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 05-08 ROOM3 16:10~16:40 ABPM-guided antihypertensive treatment in CKD ±èÀ±¹Ì(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 05-08 ROOM3 16:40~17:10 Application of Artificial intelligence in electrolyte and blood pressure disorders ¿ÀÅ·Å(Àü³²ÀÇ´ë)
±³À°½Ã°£ 05-08 ROOM3 17:10~17:30 ÆгÎÅäÀÇ ()